80930 – New trends on the treatment of osteoporosis important for primary care | Tailoring lipid therapy in a post-Covid setting

0,00 $

New trends on the treatment of osteoporosis important for primary care | Tailoring lipid therapy in a post-Covid setting

28 still available

Description

Objectifs d'apprentissage

LES PLACES SONT LIMITÉES

By the end of the program, participants will be able to :

New trends on the treatment of osteoporosis important for primary care
1. Cite screening criteria for osteoporosis, define screening intervals and post treatment testing intervals of serial bone density tests;
2. Identify which patients will benefit the most and which will benefit the least from pharmacotherapy to prevent fragility fractures;
3. Apply clinical methods for effective screening & treatment during the pandemic making sure patients don’t fall by the wayside;
4. Determine the various treatment options for high risk osteoporotic patients and learn how to choose amongst the pharmacological agents.

Tailoring lipid therapy in a post-Covid setting
1. Present and implement the 2021 Canadian lipid guidelines in practice using clinical case examples;
2. Cite and apply impactful PCSK9i data from relevant studies;
3. Present practical cases on to identify appropriate patient types most likely to benefit fromPCSK9i therapy and cite RAMQ criteria for eligible patients;
4. Present the data on risk reduction presented in the Supplementary Material 2021 Canadian Cardiovascular Society Guidelines Supplement 4 ''Expected Benefits of Various Health Behaviour Changes'' and compare the benefits to the statins to help motivate our patients already on pharmacotherapy for synergisic benefits and for those not on pharmacotherapy.

Conférenciers

Président de séance : Dr Jonathan Singerman. Conférences données par les Drs Peter Assimakopoulos et Michael Tsoukas.

Horaire

De 18 h 00 à 18 h 05, Accueil
De 18 h 05 à 19 h 35, Conférence
De 19 h 35 à 19 h 40, Pause
De 19 h 40 à 21 h 10, Conférence

Questions

Pour toutes questions, SVP communiquer avec Mme Nadine Grunberg d'Amgen Canada au 514 515-3752 ou à ngrunber@amgen.com.

Reconnaissance des activités éducatives

L’Association des médecins omnipraticiens de Montréal, sous l’agrément parapluie de la FMOQ, reconnaît 3 heures de crédits de catégorie 1 aux participants à cette activité. Numéro FMOQ pour récupérer votre attestation : 80930.

Formation subventionnée

Cette activité bénéficie d’une subvention à visée éducative d'Amgen Canada.

Event Details

Date: 2022-02-09

Start time: 18:00 EST

End time: 21:10 EST

Email: ngrunber@amgen.com